CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
PGX Technology
PGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGX
Stock Information CZO
TSX Venture
CZO
Change
Volume
Day Range
52 Week Range
Stock Information CRPOF
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Corporate Presentation
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View Presentation
Products
Ceapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Latest News
Ceapro Inc. to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Sep 8, 2021 | Read More
Ceapro Inc. Reports 2021 Second Quarter and Six-Month Financial Results and Operational Highlights
Aug 26, 2021 | Read More
Ceapro Inc. Enters into Research Collaboration with the Angiogenesis Foundation for Beta Glucan and Avenanthramides
Aug 23, 2021 | Read More
Ceapro Inc. Expands Collaboration with Montreal Heart Institute (MHI) with New Clinical Study Evaluating Flagship Product, Avenanthramide
Aug 11, 2021 | Read More